Sedation, Analgesia, and Neuromuscular Blockade: An Assessment of Practices From 2009 to 2016 in a National Sample of 66,443 Pediatric Patients Cared for in the ICU.

ABSTRACT:

Objectives

To describe the pharmaceutical management of sedation, analgesia, and neuromuscular blockade medications administered to children in ICUs.

Design

A retrospective analysis using data extracted from the national database Health Facts.

Setting

One hundred sixty-one ICUs in the United States with pediatric admissions.

Patients

Children in ICUs receiving medications from 2009 to 2016.

Exposure/intervention

Frequency and duration of administration of sedation, analgesia, and neuromuscular blockade medications.

Measurements and main results

Of 66,443 patients with a median age of 1.3 years (interquartile range, 0-14.5), 63.3% (n = 42,070) received nonopioid analgesic, opioid analgesic, sedative, and/or neuromuscular blockade medications consis

SUBMITTER: Patel AK 

PROVIDER: S-EPMC7483172 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature